Patients can access meds and labs in a single visit
AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today that it will launch a GLP-1 test panel at over 25 Austin and Temple BetterWay collection locations including Sam’s Club and Peoples Rx pharmacies-pairing GLP-1 prescriptions, including Wegovy’s new oral GLP-1 option, with BetterWay’s patient-preferred fingertip blood collection.
The FDA’s recent approval of Novo Nordisk’s Wegovy® pill-the first oral GLP-1 for weight loss-further expands access with a convenient, affordable option that is particularly suitable for needle-averse patients.
Blood testing is recommended for GLP-1 users to track metabolic shifts, weight loss, and side effects like blood sugar changes, enabling safer therapy management. BetterWay’s launch now enables patients an affordable, convenient one-stop solution.
The BetterWay GLP-1 Test Panel features hemoglobin A1c, lipid panel, comprehensive metabolic panel (CMP) and TSH. In total, the panel includes 29 tests that support safe, informed use of GLP-1 medications by helping providers and patients assess baseline health and ongoing response.
Patients can order the panel for themselves for $98, plus a $4 clinician-oversight fee and can use their FSA/HSAs. The panel can also be ordered by a provider and is covered by some health insurance plans. Customer-initiated orders include a special GLP-1 discount code for testing.
“Retail pharmacies are now a preventive health hub: shop, consult pharmacists, get convenient blood tests, and manage GLP-1s seamlessly at the same locations. This defines a modern care experience where diagnostics, therapeutics, and pharmacy services work together to make preventive care part of everyday life,” said David Stein, CEO of Babson Diagnostics.
About BetterWay Blood Testing by Babson Diagnostics
BetterWay™ is blood testing reimagined-patient-friendly fingertip blood collection with accurate lab results. One in three people skip blood testing due to anxiety, fear of needles, difficult venous access, or inconvenience. BetterWay enables blood testing without phlebotomy. This improves patient experience, increases adherence to testing, optimizes staffing efficiency, and advances health equity. BetterWay was developed by Babson Diagnostics, a science-first healthcare technology company that has become the global thought leader in the use of capillary blood for routine testing. Babson was named 2024 Medtech Company of the Year by MD + DI, 2025 SXSW Innovation Award winner for Health & Biotech, and one of Fast Company’s 2025 Most Innovative Companies in Healthcare. For more information, please visit BetterWay.com or connect with us on Instagram or LinkedIn.
Media Contact:
Jo Detavernier
Razor Sharp PR
210-803-2097
jo@razorsharppr.com
# # #
SOURCE: BetterWay Blood Testing
View the original press release on ACCESS Newswire
After selling out all previous Pangolin versions, KITS will release three additional Pangolin 3 Video…
SUNNYVALE, Calif., Jan. 30, 2026 /PRNewswire/ -- Perio charting shouldn't feel like operating a voice command…
Company Management Explores Public Listing in the U.S. and Highlights Launch of New Biomarker Tech…
Enhanced visibility helps healthcare systems measure landfill diversion, compliance, and operational performanceSAN ANTONIO, Jan. 29,…
NWEA MAP®, STAR®, aReading, AUTOreading, and WIST Results Reflect Gains in Reading and Language SkillsJACKSONVILLE,…
WASHINGTON, Jan. 29, 2026 /PRNewswire/ -- Zivian Health, the healthcare workforce technology company, today announced…